Latest Posts
About This Stock
More About This Stock
Read
Read
What A Trip: Psychedelic Medicine Company MindMed Shares Rocket 50% After Positive Data
Article By:
Tyler Durden
Sunday, March 10, 2024 1:00 PM EDT
Shares of clinical stage biopharmaceutical company MindMed were heavily monitored on Friday after the stock rocketed higher during Thursday's cash session by more than 51% on more than 30x the company's average volume.
In this article: MNMD
Psychedelic Stocks Index Popped 8% Last Week, Led By Incannex
Article By:
Lorimer Wilson
Sunday, February 18, 2024 6:14 PM EDT
IXHL 's increase was based on the successful completion of an Investigational New Drug meeting with the FDA regarding the development of CannQuit-N for tobacco smoking cessation and relapse control.